Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pargeverine SCHEMBL30728632 | 0.99 | CYP3A4 (0.53) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Dimenoxadol SCHEMBL25993 | 0.85 | CYP3A4 (0.68) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Dimenoxadol SCHEMBL2886211 | 0.84 | CYP3A4 (0.70) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Dimenoxadol SCHEMBL79044 | 0.84 | CYP3A4 (0.70) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Dimenoxadol SCHEMBL5854258 | 0.83 | CYP3A4 (0.69) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Dimenoxadol SCHEMBL2204879 | 0.82 | CYP3A4 (0.67) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Denaverine SCHEMBL147346 | 0.80 | CYP3A4 (0.52) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| Denaverine SCHEMBL9569397 | 0.79 | CYP3A4 (0.54) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| SCHEMBL8134540 | 0.76 | ALDH1A1 (0.50) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 | |
| SCHEMBL8134339 | 0.76 | CHRM1 (0.71) | CYP3A4CYP2D6ALDH1A1POLBCHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170281596-A1 | PHARMACEUTICAL COMBINATION CONTAINING AN ANALGESIC AGENT AND AN ANTISPASMODIC AGENT | DIFFUCAP CHEMOBRAS QUÍMICA E FARMACÊUTICA LTDA. (BR) | 2017-10-05 | — | — | US | claimed |
| EP-3195864-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN ANALGESIC AGENT AND AN ANTISPASMOSDIC AGENT | Diffucap Chemobras Quimica E Farmaceutica Ltda. (BR) | 2017-07-26 | — | — | EP | claimed |
| US-20150150953-A1 | PHARMACEUTICAL COMPOSITION ADAPTED FOR ORAL ADMINISTRATION AND THE PROCESS FOR ITS PREPARATION, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, BASED ON AN INTESTINAL MOTILITY MODIFIER AND a-D-GALACTOSIDASE | POSI VISIONARY SOLUTIONS LLP (GB) | 2015-06-04 | — | — | US | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| WO-2014141075-A1 | COMBINATIONS WITH PROBIOTICS FOR RESTORING ALTERATIONS IN INTESTINAL FUNCTION | SIEGFRIED RHEIN S.A. DE C.V. (MX) | 2014-09-18 | — | — | WO | claimed |
| US-20130344145-A1 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | POSI VISIONARY SOLUTIONS LLP (GB) | 2013-12-26 | — | — | US | claimed |
| CN-103429237-A | Orally administered pharmaceutical composition for treating irritable bowel syndrome comprising intestinal motility regulator, gas retention preventing agent and digestive enzyme, and preparation method thereof | POSI VISIONARY SOLUTIONS LLP | 2013-12-04 | — | — | CN | claimed |
| CN-103392000-A | Orally administered pharmaceutical composition comprising intestinal motility modulator and alpha-D-galactosidase for preventing and treating irritable bowel syndrome and preparation method thereof | POSI VISIONARY SOLUTIONS LLP | 2013-11-13 | — | — | CN | claimed |
| EP-2641968-A2 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND -D-GALACTOSIDASE | Posi Visionary Solutions LLP (GB) | 2013-09-25 | — | — | EP | claimed |
| EP-2641598-A2 | ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER, AN AGENT THAT PREVENTS GAS RETENTION, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | Posi Visionary Solutions LLP (GB) | 2013-09-25 | — | — | EP | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-20230390224-A1 | UNITARY ORAL DOSAGE FORM IN BASE OF SPHERICAL AND/OR SPHEROIDAL SHAPED PARTICLES | ATOMIC PHARMACEUTICS INC. (US) | 2023-12-07 | — | — | US | disclosed |
| WO-2023235542-A1 | UNITARY ORAL DOSAGE FORM IN BASE OF SPHERICAL AND/OR SPHEROIDAL SHAPED PARTICLES | ATOMIC PHARMACEUTICS INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-6331289-B1 | ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED | NYCOMED IMAGING AS (NO) | 2001-12-18 | — | — | US | disclosed |
| US-6264917-B1 | MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT | NYCOMED IMAGING AS (NO) | 2001-07-24 | — | — | US | disclosed |
| US-6261537-B1 | TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES | NYCOMED IMAGING AS (NO) | 2001-07-17 | — | — | US | disclosed |